Paper35614865
Retinal Ganglion Cell Death in Glaucoma: Advances and Caveats.
Yang Y and 1 other. Curr Eye Res, 2023. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. Retinal Ganglion Cell Death in Glaucoma: Advances and Caveats. Papers, record 35614865. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35614865
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glaucoma | Major topic |
| Ocular Hypertension | Major topic |
| Animals | |
| Retinal Ganglion Cells | |
| Apoptosis | |
| Cell Death | |
| Disease Models, Animal |
Source PubMed
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42819585 | Ferroptosis in retinal neurodegeneration: mechanistic vulnerability, therapeutic targeting, and translational barriers. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42819585 | PubMed |
| 42666667 | Gap junction protein connexin 36 proteostatic mechanisms in photoreceptor cells subjected to excitotoxic stress. | Acta Biochim Pol | 2026 | https://conductscience.org/library/papers/42666667 | PubMed |
| 42497345 | Cell death analysis of inducible, titratable neurodegenerative disease models in zebrafish and human stem cell-derived retinal organoids. | Dis Model Mech | 2026 | https://conductscience.org/library/papers/42497345 | PubMed |
| 42310662 | An ROS-responsive, RGC-targeted nanotherapeutic strategy with a TRPV4 antagonist restores autophagic flux and protects RGCs in a rat model of chronic ocular hypertension. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/42310662 | PubMed |
| 42294393 | Emerging Roles of Regulated Cell Death-mediated Inflammation in Pathophysiology of Ocular Diseases. | J Ophthalmic Vis Res | 2026 | https://conductscience.org/library/papers/42294393 | PubMed |
| 42225629 | Deficient autophagy in retinal ganglion cells impairs the degradation of intracellular organelles, leading to neurodegeneration. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/42225629 | PubMed |
| 42194266 | Retinal Ganglion Cell Degeneration in Glaucoma: Systematic Review. | Bioengineering (Basel) | 2026 | https://conductscience.org/library/papers/42194266 | PubMed |
| 41754895 | Research Advances in Glanimal Models of Glaucoma: Exploring Multidimensional Mechanisms and Novel Therapeutic Strategies. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/41754895 | PubMed |
| 41367892 | Machine Learning-Derived Diverse Regulated Cell Death Patterns for Therapeutic Target Identification in Glaucoma. | Int J Gen Med | 2025 | https://conductscience.org/library/papers/41367892 | PubMed |
| 40621053 | Mechanobiology in the eye. | NPJ Biol Phys Mech | 2025 | https://conductscience.org/library/papers/40621053 | PubMed |
| 40195959 | VPS35-Retromer: Multifunctional Roles in Various Biological Processes - A Focus on Neurodegenerative Diseases and Cancer. | J Inflamm Res | 2025 | https://conductscience.org/library/papers/40195959 | PubMed |
| 39125579 | Optimization of an Ischemic Retinopathy Mouse Model and the Consequences of Hypoxia in a Time-Dependent Manner. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39125579 | PubMed |
| 39061946 | Ocular Inflammation and Oxidative Stress as a Result of Chronic Intermittent Hypoxia: A Rat Model of Sleep Apnea. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/39061946 | PubMed |
| 38694874 | Identification of immune-related biomarkers for glaucoma using gene expression profiling. | Front Genet | 2024 | https://conductscience.org/library/papers/38694874 | PubMed |
| 38297331 | A time window for rescuing dying retinal ganglion cells. | Cell Commun Signal | 2024 | https://conductscience.org/library/papers/38297331 | PubMed |
| 38212307 | Clinical applications of stem cell-derived exosomes. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/38212307 | PubMed |
| 38133508 | Resveratrol Alleviates Retinal Ischemia-Reperfusion Injury by Inhibiting the NLRP3/Gasdermin D/Caspase-1/Interleukin-1β Pyroptosis Pathway. | Invest Ophthalmol Vis Sci | 2023 | https://conductscience.org/library/papers/38133508 | PubMed |
| 37936170 | Spatiotemporal roles of AMPK in PARP-1- and autophagy-dependent retinal pigment epithelial cell death caused by UVA. | J Biomed Sci | 2023 | https://conductscience.org/library/papers/37936170 | PubMed |
| 37631087 | Pharmaceutical Approaches to Normal Tension Glaucoma. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37631087 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35614865
GET https://conductscience.org/api/papers/v1/35614865/authors